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suggests that CCR5-positive T cells may play a role in intersti-Expression of the C-C chemokine receptor 5 in human kidney
tial processes leading to fibrosis. Further studies are requireddiseases.
to define the pathophysiological relevance of these cells inBackground. Chemokines are proteins that contribute to
progressive renal diseases.the migration of leukocytes to sites of tissue injury. CCR5 is
a receptor for the C-C chemokine RANTES, which is expressed
in inflammatory kidney diseases and transplant rejection.
Methods. In order to study the distribution of CCR5, we Chemokines are members of a large and rapidly grow-
developed a series of monoclonal antibodies against human
ing family of small chemotactic proteins [1]. AccordingCCR5. These antibodies were then evaluated by flow cytome-
to the position of the first two of four conserved cysteinetry, Western blot, and immunohistochemistry on formalin-
fixed, paraffin-embedded tonsils. Eighty biopsies from patients residues, these cytokines are divided into subgroups [2].
with membranous glomerulonephritis (N 5 9), IgA nephropa- The C-C chemokine RANTES (regulated upon activa-
thy (N 5 10), lupus nephritis (N 5 10), membranoproliferative tion of normal T cell expressed and secreted), a 68-amino
glomerulonephritis (N 5 10), acute interstitial nephritis (N 5
acid protein, can be expressed by stimulated fibroblasts13), chronic interstitial nephritis (N 5 10), acute transplant
[3], mesangial cells [4], and tubular epithelial cells [5].rejection (N 5 9), and chronic transplant rejection (N 5 9)
The role of chemokines in the cellular infiltrate of in-were stained for CCR5 and CD3 expression in parallel sections.
Results. One monoclonal antibody (MC-5) showed a single flammatory renal diseases has been studied in vitro [4]
protein band of approximately 38 kD corresponding to CCR5 and in vivo [6]. In the mouse model of anti-glomerular
in Western blot. By indirect immunohistochemistry, a cell basement membrane nephritis, an up-regulation ofmembrane signal was detected exclusively on mononuclear
RANTES mRNA was observed [6]. Blocking theinflammatory cells. All control stainings with an isotype-
RANTES effect by MetRANTES led to a decrease ofmatched mouse IgG2a were negative. CCR5-positive cells were
identified in areas of interstitial infiltration in biopsies of proteinuria and a decreased number of T cells [7]. Ele-
chronic glomerulonephritis, interstitial nephritis, and trans- vated RANTES levels have been described in patients
plant rejection. The staining of CCR5 showed the same distri- with human immunodefficiency virus (HIV) nephropa-bution as CD3-positive T cells. In patients with impaired renal
thy (Kimmel PL et al, abstract; J Am Soc Nephrol 5:279,function, a significantly higher number of CCR5-positive cells
1994) and during human transplant rejection [8]. Thewere found as compared with patients with normal renal func-
tion. In contrast to the prominence of CCR5-positive cells in production of RANTES by cultured tubular cells can be
the interstitial infiltrate, the number of CCR5-positive cells stimulated not only by proinflammatory cytokines [5],
within the glomeruli was low, even in cases with proliferative but also by exposure to albumin [9].
glomerulonephritis. No CCR5 expression could be detected
Chemokine receptors are classified according to theiron intrinsic cells of glomerular, tubular, or vascular structures.
ligands into the CC, CXC, and CX3C receptor familiesConclusions. The pattern of CCR5 and CD3 cell infiltration
(CCR, CXCR, and CX3CR) [10]. These receptors are
seven-transmembrane–spanning G-protein–coupled pro-
1 See Editorial, p. 347. teins [11]. CCR5 is a receptor for the C-C chemokines
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Approximately 20 to 30% of peripheral T cells and Generation and characterization of the monoclonal
anti-CCR5 antibody MC-510% of monocytes are CCR5 positive [19]. To date,
little is known about the expression and distribution of BALB/c mice were immunized intraperitoneally for
chemokine receptors on different cells during renal dis- seven times with 107 CHO/CCR5 cells as described ear-
eases. Schadde et al (abstract; Schadde E et al, J Am lier in this article. Four days after the last injection, the
Soc Nephrol 8:485, 1997) described the expression of the spleens were removed, splenocytes fused with the P3 3
chemokine receptors 1 through 5 in a mouse model of 63-Ag8 myeloma cell line, and the cells plated on six 96-
anti-glomerular basement membrane nephritis. An up- well, flat-bottomed microtiter plates. Supernatant from
regulation of CCR1, -2, -3 and -5 was observed by reverse each well, containing approximately 10 hybridomas, was
transcription-polymerase chain reaction (RT-PCR) in tested by flow cytometry analysis on CHO/CCR5 versus
CHO/CXCR4 cells. To ensure homogeneity, hybridomakidney cortex, in the tubular fraction, and was most
cells from a well with specific binding activity againstprominent in the glomerular fraction. The RT-PCR tech-
CCR5 were cloned twice by limited dilution. The speci-nique, however, did not permit an assignment of the
ficity of the resulting monoclonal anti-CCR5 antibodyCCR expression to specific cells. By in situ hybridization,
MC-5 was tested on CHO cells overexpressing the recep-CCR5 expression was detected in infiltrating cells in allo-
tors CCR1-3 and CXCR4 (not shown), as well as ongraft rejection but not in intrinsic renal cells of the nor-
peripheral blood mononuclear cells (PBMCs) from twomal kidney [20]. In a study on cryosections, Rottman et
donors with a homozygous D32 deletion in the CCR5al described CCR5 by immunohistochemistry. In one
gene. In all cases, no binding of the antibody MC-5 wascase of interstitial nephritis, CCR5 was found on intersti-
detected.tial infiltrating cells and endothelium and vascular
smooth muscle cells [21]. As RANTES seems to play an
Detection of cell surface CCR5 by flow
important role in different animal models of inflamma-
cytometry analysis
tory kidney diseases, as well as in human renal diseases
Five 3 105 CHO/CCR5 cells or PBMCs were incu-and transplant rejection, we aimed to characterize the
bated with supernatant or purified antibody from thecellular distribution of the RANTES receptor CCR5 in
MC-5 hybridoma for 30 minutes on ice. After threekidney diseases. The identification of CCR5-positive
washing steps with phosphate-buffered saline (PBS),cells is important in the characterization of infiltrating
fluorescein isothiocyanate (FITC)-conjugated rabbitcells and their potential role in the inflammatory process.
anti-mouse F(ab)2 fragments were added for 30 minutesThis information is a prerequisite for eventual therapeu-
at a dilution of 1:50 (F313; Dako, Carpinteria, CA, USA).tic studies to block CCR5. Therefore, we examined the
Cells were washed three times, incubated for 10 minutesCCR5 expression pattern in a series of inflammatory
in 10% mouse serum, and finally stained with PE- orkidney diseases and during renal transplant rejection on
Tricolor-conjugated anti-CD4 or anti-CD8 antibodiesformalin-fixed and paraffin-embedded renal biopsies by
(CALTAG). After a final washing step, cells were ana-
immunohistochemistry. We found that the CCR5-posi-
lyzed on a flow cytometer (FACSCalibur; Becton-
tive cells were primarily CD3-positive cells, and in all
Dickinson, Mountain View, CA, USA).
disease, entities were present almost exclusively in the
interstitium. The mean number of CCR5-positive cells Immunoblotting
was found to be significantly higher in patients with glo- For immunoblotting, confluent CHO cells were washed
merular diseases and impaired renal function than in twice with PBS and lyzed with hot Laemli buffer. The
patients with normal renal function. cell lysate was boiled immediately for five minutes and
separated by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE; 10% acrylamide gel). GelsMETHODS
and polyvinylidene fluoride (PVDF) membrane (Im-
Generation of the CHO/CCR5 cell line mobilon-P, Millipore Corp., Germany) were equili-
Dihydrofolate reductase (DHFR)-deficient Chinese brated with transfer buffer (Tris 25 mm; glycine 192 mm;
hamster ovary (CHO) cells were stably transfected with methanol 20%; pH 8.3) for 10 minutes. Electroblotting
the cDNA sequence of CCR5 as previously described was performed with the Trans-Blot SD Semi-Dry Trans-
[22]. One clone growing in the presence of 20 nm metho- fer Cell (Bio-Rad, Richmond, CA, USA) using a con-
trexate expressed high levels of CCR5 and was chosen stant current of 3 mA/cm2 for 45 minutes. The mem-
for immunization of BALB/c mice. Full functional activ- branes were stained in Ponceau solution (Ponceau Red
ity of the overexpressed CCR5 protein was demon- 0.5%, glacial acetic acid 1%) for five minutes to control
strated by receptor down-modulation and calcium influx the protein transfer. Blocking was done with 10% nonfat
dry milk in TBST (Tris-HCl 20 mm, sodium chlorideinduced by RANTES (data not shown).
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137 mm, Tween 20; 0.5%; pH 7.6) for one hour. Blocking 1:400; Dako), macrophages (CD68, 1:100; Dako) and B
cells (1:25, CD79a, Dako).solution was washed away in TBST for five minutes.
MC-5 was diluted 1:100 in TBS with 10% nonfat dry
Patient characteristics and quantitative evaluationmilk. A first antibody was incubated overnight at 48C.
of biopsiesMembranes were rinsed in TBST twice and washed in
TBST (1 3 15 min, 2 3 5 min). A secondary antibody We evaluated a total of 80 human kidney biopsies; the
clinical data are summarized in Table 1. All biopsies[horseradish peroxidase (HRP) conjugated rabbit anti-
mouse; Dako] was used in a dilution of 1:2000 for 30 were stained with anti-CCR5 and anti-CD3 in parallel.
Positive cells were counted in 10 high-power fieldsminutes. Afterward, membranes were washed three
times in TBST and once in TBS for 15 minutes each. (3400) to a maximum of 50 cells. Cell count per intersti-
tium and glomerulus were separately evaluated by anFor detection, we used the ECL solution (Amersham
Life Science, Arlington Heights, IL, USA) following the observer without the knowledge of either the underlying
disease or the serum creatinine. The overall positive cellmanufacturer’s protocol.
number reflected the positive cells within the glomerulus
Immunohistochemistry plus the cells in the tubulointerstitium. Cell counts were
compared by Wilcoxon test, and a P , 0.05 was consid-Four monoclonal antibodies and a polyclonal rabbit
serum against CCR5 were tested on a formalin-fixed, ered as statistically significant. Bars give the standard
error of the mean (sem).paraffin-embedded tissue of human tonsils. Isotype-
matched mouse IgG was used on parallel sections as
a negative control. By enzyme-linked immunosorbent
RESULTS
assay (ELISA), IgG concentration of the diluted super-
Characterization of the monoclonal antibody MC-5natant was approximately 3 mg/ml, and an excess concen-
against CCR5tration of 10 mg/ml IgG2a was used as a negative control.
One antibody (MC-5) turned out to be suitable on paraf- By flow cytometry analysis, MC-5 detected CCR5 on
overexpressing CHO cells (data not shown) and onfin-embedded material with the following protocol.
Slides were deparaffinized and rehydrated (10 min in PBMCs isolated from peripheral blood of normal donors
(Fig. 1A). As the negative control, isotype-matchedxylol, 10 min in 100% ethanol; 96, 70, 50% ethanol and
aqua dest. for a few seconds each). Endogenous peroxi- mouse IgG2a, untransfected CHO cells, and PBMCs
from individuals homozygous for the D32-CCR5 alleledase activity was blocked by H2O2 in methanol (5 ml of
30% H2O2 in 70 ml methanol) for 15 minutes. Slides were (lacking CCR5 expression) were used (Fig. 1A). Immu-
noblotting showed a single band of approximately 38 kDrinsed in Tris buffer (Tris 0.05 m, pH 7.5). In preliminary
experiments, we established that autoclaving of the for- in cells overexpressing CCR5 (Fig. 1B), but not in cells
overexpressing CXCR4. These results confirm the speci-malin-fixed and paraffin-embedded tissue slides pro-
vided better results than microwave treatment or prote- ficity of MC-5 for CCR5.
On sections of formalin-fixed and paraffin-embeddedase digestion. Therefore, all stainings were performed
after autoclaving for 10 minutes at one bar in a citrate tonsils (Fig. 1C), we found CCR5-positive cells mainly in
the interfollicular region with a cell membrane-stainingbuffer [Stock-Solution 10X; citrate-monohydrate 0.01 m
(244; Merck, Darmstadt, Germany); pH 6; final concen- pattern. In the follicles, only a few cells were positive.
The pattern of CCR5-positive cells correlated well withtration diluted in aqua dest]. After 10 minutes of auto-
claving and 40 minutes of cooling, slides were again the CD3-positive T cells, but not with the distribution of
CD68-positive macrophages and CD79-positive B cells.rinsed in Tris buffer for 15 minutes. The first antibody
(MC-5, 1:10 in PBS with 10% human serum) was incu- These results demonstrate the feasibility of staining for
CCR5 with MC-5 in paraffin-embedded tissue, and showbated for one hour. After rinsing with Tris buffer, one
drop of Link (biotinylated goat anti-mouse immunoglob- that mostly CD3-positive T cells stain for CCR5.
ulins; Super Sensitive Ready to Use Kit; BioGenex, San
Staining for CCR5 in human kidney biopsiesRamon, CA, USA) was added and incubated for 30
minutes. The same was done with Label (peroxidase- Biopsies from 80 patients (43 men and 37 women)
with various renal diseases were included in this study.conjugated streptavidin; Super Sensitive Ready to Use
Kit; BioGenex). Slides were briefly rinsed in PBS. Stain- Irrespective of the type of kidney disease, CCR5 expres-
sion was only found on infiltrating mononuclear cells.ing was done with AEC according to the manufacturer’s
protocol (Super Sensitive Ready to Use Kit; BioGenex). No expression of CCR5 could be detected on intrinsic
cells of the glomerulus, tubuli, or vasculature. The pat-Staining was followed under the microscope. Slides were
counterstained with hemalaun for approximately one mi- tern of distribution between CCR5- and CD3-positive
cells in parallel tissue sections was closely comparable.nute and embedded in Aquatex (Merck). To compare
the expression pattern, we used markers for T cells (CD3, The correlation between CD3- and MC-5–positive cells
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Table 1. Characteristics of the patients at the time of biopsy (median and range)
Age Serum creatinine Sex ratio
Renal disease N years mg/dl female:male
Membranous glomerulonephritis 9 70 (39) 0.9 (4.7) 3:6
IgA nephropathy 10 41 (55) 1.0 (5.6) 6:3
Lupus nephritis 10 27 (45) 1.1 (1.7) 9:1
Membranoproliferative glomerulonephritis 10 51 (54) 1.8 (2.5) 6:4
Acute interstitial nephritis 13 46 (59) 8.2 (17.6) 5:8
Chronic interstitial nephritis 10 43 (60) 2.6 (11.7) 5:5
Acute transplant rejection 9 35 (36) 1.3 (3.1) 4:5
Chronic transplant rejection 9 37 (52) 2.5 (3.5) 3:6
also supports the interpretation that the CCR5-positive exceeded the negligible number of CCR5 with 0.2 and
CD3 with 0.1 positive cells by far. In contrast, the numbercells are mainly CD3-positive T cells (Fig. 2).
of CD68-positive macrophages (7.5 6 0.9) within the
Membranous glomerulonephritis interstitium was lower than the number CCR5- (11.3 6
2.4) and the CD3- (18.2 6 3.9) positive cells. AlthoughWe studied nine cases of membranous glomerulone-
phritis. This was the disease group with the highest me- there were very few CD3- and CCR5-positive cells in
the glomerulus of systemic lupus erythrematosus (SLE)dian age (Table 1). Eight patients suffered from early
membranous glomerulonephritis (stages I and II), and patients, a strong infiltrate with CD68-positive macro-
phages was apparent (Fig. 4F).one had stage III disease.
No CCR5-positive cells were found within the glomer-
Membranoproliferative glomerulonephritisulus (Fig. 3A; note the different scale for glomerular and
interstitial infiltrates; Fig. 4 A, B). The mean CCR5- A total of 10 biopsies with the typical features of mem-
branoproliferative glomerulonephritis was studied. Thepositive cell number per high-power field of cortical tis-
sue was approximately one. In only one case with chronic number of CCR5-positive cells within the glomerulus
appeared to be higher than in other glomerulopathies,stage III disease, renal insufficiency and severe intersti-
tial fibrosis was a mean of 12 positive cells per high- whereas the mean CCR5-positive cell infiltrate in the
cortical tissue and the percentage of CCR5-positive cellspower field observed in the cortical tissue.
were similar to the other forms of glomerulonephritis
IgA nephropathy (Fig. 3A and Fig. 4 G, H, and Fig. 5).
Ten patients had the typical findings of IgA nephropa-
Acute interstitial nephritisthy. As in membranous glomerulonephritis, no CCR5-
positive cells were found within the glomerulus (Fig. We studied 13 biopsies of patients with acute intersti-
tial nephritis. This was the group with the highest median3A). Three patients with impaired renal function showed
an interstitial infiltrate with prominent CCR5 expression serum creatinine value at the time of biopsy (Table 1).
The histological picture ranged from mild signs of tubu-(Fig. 3B and Fig. 4 C, D).
lar damage with a minimal interstitial infiltrate to a prom-
Lupus nephritis inent mononuclear infiltrate with tubulitis (Fig. 6 A, B)
and interstitial edema. There was usually no or only mildBiopsies from 10 cases of diffuse proliferative lupus
nephritis (as defined by WHO IV) were examined. This interstitial fibrosis. In four patients, eosinophils were de-
tected in the infiltrate. Very few, if any, CCR5-positivewas the group with the lowest median age and 9 of the
10 patients were women. In spite of the proliferative cells were found in the glomerulus (Fig. 3A).
In contrast, in the interstitium, a mean of 20 CCR5-nephritis, the number of CCR5-positive cells in the glo-
merulus was low (Fig. 3A). In contrast, there was a con- positive cells (Fig. 3B) was found with an accentuation
in the peritubular region (Fig. 6 A, B). At a highersiderable CCR5-positive mononuclear interstitial infil-
trate (Fig. 4E). The mean overall CCR5-positive cell magnification, CCR5-positive cells could be detected
that infiltrate the tubular epithelium in areas with tubul-number was 11.5 per high-power field (Fig. 3B). In some
cases, the CCR5-positive infiltrate was pronounced in itis (Fig. 6 C, D).
the periglomerular region (Fig. 4E). Nine biopsies were
Chronic interstitial nephritisevaluated for the number of CD68-positive macro-
phages. A mean of 7.5 6 0.9 CD68-positive cells was Ten patients showed a histological pattern of chronic
interstitial nephritis with an interstitial infiltrate, intersti-found in the interstitium and 9.2 6 1.7 within the glomer-
ulus per high-power field. Therefore, the number of tial fibrosis, and sometimes signs of tubulitis. Tubuli
showed signs of atrophy. The CCR5-positive infiltrateCD68-positive macrophages within the glomerulus (9.2)
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Fig. 1. Flow cytometry analysis of peripheral blood mononuclear cells
(PBMCs) from normal donors (A, left) and donors homozygous for
the D32/D32 deletion of CCR5 (A, right), stained with MC-5 for CCR5
and a monoclonal antibody against CD4. (B) Immunoblot with protein
from Chinese hamster ovary (CHO) cells overexpressing CCR5 or
CXCR4. A single protein band is only detected with the monoclonal
antibody MC-5 in cells overexpressing CCR5, but not in those overex-
pressing CXCR4. (C) CCR5-positive cells are found mainly in the
interfollicular region in formalin-fixed, paraffin-embedded human ton-
sils. A CCR5-positive membrane staining pattern of small lymphocytes
is observed. Negative control with isotype-matched IgG2a (magnifica-
tion 3100, left panel). Positive staining with MC-5 (magnification 3100,
center panel). Membrane staining pattern with MC-5 (magnification
3600, right panel).
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Fig. 2. Correlation between the mean CCR5-positive and the mean
CD3-positive cells in cortical tissue from biopsies with various kidney
diseases (y 5 0.77x – 1.84; R2 5 0.86).
was less prominent, and the percentage of CCR5-positive
T cells was smaller than in acute interstitial nephritis
(Fig. 3B and Fig. 6 E, F).
Transplant rejection
We studied a total of 18 transplant biopsies. Half of
them showed signs of acute rejection. Biopsies were per-
formed in the mean 32 days after transplantation. Seven
of the nine acute rejections were classified as grade I
and one as grade II according to the Banff classification.
In two cases, vascular rejection with endothelialitis was Fig. 3. Mean cell count of CCR5-positive cells per glomerular high-
power fields (A) and cortical high-power field (B). Please note thepresent (Fig. 7 A, B), and the rest of the cases showed
different scales. Abbreviations are: ac.int., acute interstitial nephritis;mild to severe tubulitis. In one case, prominent glomeru-
ch.int., chronic interstitial nephritis; IgAN, IgA nephropathy; SLE, lu-litis was present. The mean cell count of CCR5-positive pus nephritis; MN, membranous nephropathy; MPGN, membranoproli-
cells and the percentage of CCR5-expressing T cells (Fig. ferative glomerulonephritis; ac.reject, acute transplant rejection; ch.re-
ject, chronic transplant rejection.5) was the highest in this group. CCR5-positive cells were
seen in all areas with mononuclear infiltrates. CCR5-
positive cells invaded the epithelium of tubuli (Fig. 7C).
In cases of vascular rejection, CCR5-positive cells were the time of biopsy (normal serum creatinine; creatinine
found in the subendothelial region (Fig. 7 A, B). Interest- between 1.2 and 3; and creatinine .3 mg/dl), the mean
ingly, in the one case with prominent transplant glomeru- cell count rose from 3.9 6 1.3 in the normal to 14.4 6
litis, a considerable number of CCR5 (1.4 per high-power 1.1 in the group with creatinines .1.2 to 3.0 to 19.8 6
field)- and CD3 (2.4 per high-power field)-positive cells 2.9 positive cells in the group with creatinine values over
were present within the glomerulus. Overall, however, 3 mg/dl (Fig. 8). A similar increase was found for CD3-
the mean CCR5-positive cells within the glomerulus was positive T cells with 7.8 6 2.5 in the normal creatinine
comparable to the primary glomerulopathies. group, to 21.8 6 1.3 and 28.4 6 2.9 in the over 3 mg/dl
Nine patients showed signs of chronic allograft ne- creatinine group, respectively. Ten cases had to be ex-
phropathy with mild to severe interstitial fibrosis (Fig. 7 cluded because of unknown serum creatinine values at
D, E) and, in most cases, prominent intima-fibrosis. In the time of biopsy. As the interstitial infiltrate has been
three cases, focal-segmental glomerulosclerosis was pres- shown to be an important predictor of renal survival
ent. The CD3- and CCR5-positive infiltrate was essen- [32], we studied the mean cell count of CD3- and CCR5-
tially interstitial with a mean of 15.6 CCR5-positive cells positive cells in patients with glomerulonephritis with
per high-power field (Fig. 3B). normal and impaired renal function. Figure 8 shows a
significantly higher number of CCR5-positive cells in
Relationship between CCR5-positive cells and patients with glomerulonephritis and impaired renal
serum creatinine function. CD3-positive T cells were also found in a sig-
When CCR5-positive cells were evaluated irrespective nificantly higher number in patients with impaired renal
function.of diagnosis but according to the serum creatinine at
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renal insufficiency [23]. We found a prominent expres-
sion of CCR5 in the interstitial infiltrate. The distribution
of cells indicated that these were mainly T cells. The
highest number of CCR5-positive cells was found in
acute transplant rejection and in cases with acute intersti-
tial nephritis. The distribution of CCR5-positive cells
that was observed by immunohistology in transplant re-
jection is comparable to the results reported by Eitner
et al with in situ hybridization [20]. Among the primary
glomerular diseases, lupus nephritis showed the highest
number of CCR5-positive cells within the interstitium,
followed by cases with membranoproliferative glomeru-Fig. 5. Percentage of CCR5-positive cells among the CD3-positive cells
lonephritis. The percentage of CCR5-positive T cells (43in the cortical tissue of biopsies according to the disease entity. Abbrevi-
ations are: ac.int., acute interstitial nephritis; ch.int., chronic interstitial to 63%) within the interstitial infiltrate was consistently
nephritis; IgAN, IgA nephropathy; SLE, lupus nephritis; MN, membra- higher than in the peripheral blood (20 to 30%), butnous nephropathy; MPGN, membranoproliferative glomerulonephritis;
differed little between the various types of glomerularac.reject, acute transplant rejection; ch.reject, chronic transplant rejec-
tion. diseases. Hooke, Gee, and Atkins described the intersti-
tial leukocyte populations in biopsies of various forms
of glomerulonephritis [24]. The percentage of T cells in
cases with proliferative glomerulonephritis ranged be-
DISCUSSION tween 39 and 77% [24]. A T-cell predominance in the
We studied the distribution of CCR5-positive cells in interstitial infiltrate has been noted by different investi-
some of the most common renal diseases, including renal gators in chronic glomerulonephritis, as well as in inter-
transplant rejection. The most important findings are: stitial nephritis, and has been related to progressive dis-
(a) a prominent CCR5-positive interstitial infiltrate con- ease [25].
sisting mainly of T cells, even in cases of primary glomer-
CD3-positive, CCR5-positive cells in glomeruliular disease; (b) the rare occurrence of CCR5-positive
cells within the glomerulus, even in cases with consider- A striking result of our study is the rare appearance of
able glomerular CD68-positive macrophage infiltration; CD3-positive, CCR5-positive cells within the glomerulus
(c) the absence of CCR5 expression by intrinsic renal even in proliferative glomerular diseases. On the other
cells in any of the kidney diseases examined; (d) a sig- hand, the interstitial infiltrate shows CCR5 expression
nificant increase of CCR5-positive interstitial cells in pa- on a prominent part of the infiltrating cells. The low
tients with renal insufficiency. Unfortunately, the limited number of T cells infiltrating the glomerulus is in agree-
amount of material available from renal biopsies did ment with the results of Hooke, Gee, and Atkins, who
not allow us to further analyze the cell infiltrate or the found a mean of 0.3 T cells per glomerular cross section
expression of adhesion molecules in parallel. in normal renal tissue, and no significant increase in
cases with glomerulonephritis [24]. Even in cases of lupus
CCR5-positive cells in glomerular disease nephritis showing a significant macrophage infiltration,
The type of leukocyte infiltration in inflammatory dis- we rarely detected CCR5-positive cells within the glo-
eases depends on the local expression of adhesion mole- merulus (9.2 CD68-positive vs. 0.2 CCR-5–positive cells
cules in concert with the release of chemokines and the within the glomerulus per high-power field). This sug-
expression of their receptors on specific leukocyte sub- gests that in immune-mediated glomerulonephritis, the
sets [4]. In renal inflammatory diseases, two types of infiltrating macrophages are either CCR5 negative or
leukocytes, that is, monocytes/macrophages and T-cell express low, undetectable amounts of immunostainable
subsets, are implicated both in the generation of in- CCR-5. This is surprising, because in other inflammatory
diseases activated monocytes and macrophages are fre-flammatory diseases and in their progression to chronic
b
Fig. 4. Parallel sections of renal biopsies from cases with glomerulonephritis. Membranous glomerulonephritis stained with anti-CD3 (A) or MC-5
(B). Note the absence of CCR5-positive cells. IgA nephropathy stained with anti-CD3 (C) or MC-5 (D). Note the periglomerular-positive infiltrate
with the same distribution pattern for CCR5 and CD3. Proliferative lupus nephritis (WHO IV) stained with MC-5 (E) or anti-CD68 (F). Note
the periglomerular cells positive for CCR5 but the absence of CCR5-positive cells within the glomerulus. In contrast, numerous CD68-positive
macrophages within the same glomerulus. Membranoproliferative glomerulonephritis stained with anti-CD3 (G) or MC-5 (H). Lobulated glomerulus
with prominent cell proliferation and occasional CD3- (↑) and CCR5-positive cells within the glomerulus (all magnification 3400). Publication of
this figure in color was made possible by a grant from Fresenius Medical Care, Homburg, Germany.
Segerer and Mack et al: CCR5 in human kidney diseases60
Fig. 6. Parallel sections of a renal biopsy from cases with acute (A–D) and chronic (E, F ) interstitial nephritis stained with anti-CD3 (A, E;
magnification 3400) or MC-5 (B, D; magnification 3400; C, magnification 3100). Note the CCR5- and CD3-positive cells in the peritubular
infiltrate with the same distribution pattern. (D) Note the massive tubulitis by CCR5-positive cells. A prominent CD3 (E)- and CCR5 (F)-positive
interstitial infiltrate in a case of chronic interstitial nephritis.
c
Fig. 7. Parallel sections of a renal biopsy from cases with acute (A, B) and chronic (D, E ) renal transplant rejection stained with anti-CD3 (A,
D) or MC-5 (B, E; magnification 3400). A case of acute vascular transplant rejection with CD3-positive cells within the vessel wall and some
subendothelial located CCR5-positive cells (↑) is illustrated in (A) and (B). (C) illustrates the infiltration of the tubular epithelium by a CCR5-
positive cell in a renal biopsy from a patient with acute transplant rejection (↑, magnification 31000). A chronic transplant rejection with marked
interstitial fibrosis is shown in D and E. Publication of this figure in color was made possible by a grant from Fresenius Medical Care, Homburg,
Germany.
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cular structures. This is consistent with in situ hybridiza-
tion results that also failed to find CCR5-positive intrinsic
renal cells [20]. An immunohistological study on CCR5
distribution in different organs has been reported on
frozen sections [21]. In a kidney with interstitial nephri-
tis, Rottman et al described CCR5 on mononuclear, vas-
cular smooth muscle, and endothelial cells. The CCR5
expression reported in this single case on cryosection is
at variance with these immunohistochemical results in
80 biopsies and the in situ hybridization studies by Eitner
et al [20].
T cell infiltrate and CCR5-positive cells
Many authors have described the important role of
interstitial fibrosis during chronic renal failure [29–32].
We found a statistically significant increase in CCR5-
positive cells and CD3-positive T cells in patients with
impaired renal function in glomerular diseases. This
relationship between the T cell infiltrate and renal in-
sufficiency is in concordance with studies on IgA ne-
phropathy [33] as well as in various other forms of glo-
merulonephritis [23]. The high degree (43 to 86%) of
CD3-positive T cells that also express CCR5 is interest-
ing as in peripheral blood only 20 to 30% of T cells are
CCR5 positive [19]. This could relate to either a specific
attraction of CCR5-positive cells into the interstitium
and/or potential activation of the T cells in the intersti-
tium by the cytokine milieu. As in different glomerular
diseases, in which the relative portion of CCR5-positiveFig. 8. Mean CCR5-positive cells in cortical tissue from biopsies irre-
spective of disease entity (A) according to normal serum creatinine, cells compared with CD3-positive cells in the interstitium
creatinine between 1.2 and 3, and creatinine over 3 mg/dl. (B) The seems to be similar, a common pathway for their accumu-results in patients with glomerulonephritis and normal (,1.2 mg/dl) or
lation and the progression of disease might be hypothe-elevated (.1.2 mg/dl) serum creatinine. The numbers in the bars indi-
cate number of biopsies examined. sized. It has been postulated that a dangerous cycle could
be initiated by the proteinuria common to glomerular
disease. The proteinuria would cause chemokine expres-
sion by tubulointerstitial cells with infiltration of chemo-quently CCR5 positive [19, 21]. The reason for the lack
kine receptor-bearing T cells and perpetuation of theof CCR5 expression by monocytes/macrophages in the
inflammatory reaction, which in turn, would contributeglomerulonephritis of SLE remains currently unknown.
to the progression of renal disease. This hypothesis isThe CCR5-negative macrophage infiltration in the glo-
supported by up-regulation of RANTES in tubular cellsmerulus may depend on different chemokines and recep-
exposed to albumin in vitro and RANTES expressiontors. For example, MCP-1 is expressed by cytokine or
by tubulointerstitial cells in experimental and humanimmune complex exposed mesangial cells [4] and seems
glomerular diseases and transplant rejection [6, 8]. Al-to play a role in macrophage influx into the inflamed
though our finding of a predominance of CCR5-positiveglomerulus in experimental [26] and human nephritis
T cells in nephritis and transplant rejection fits well to[27, 28]. In human SLE nephritis, a correlation exists
this model, we cannot establish a causal relationship thatbetween the urinary MCP-1 excretion, glomerular mac-
would require further experimental studies.rophage infiltration, and disease activity [27]. Unfortu-
In conclusion, we identified CCR5-positive, CD3-posi-nately, there are currently no antibodies against CCR2
tive cells as a prominent fraction of the interstitial infil-available that can be used on fixed tissue, and the ques-
trate of various glomerular and interstitial diseases, astion remains open as to whether or not the glomerular
well as in transplant rejection. The relationship betweenmonocyte-macrophages are CCR2 positive.
the CCR5-positive T cells and the degree of renal insuf-
No CCR5 expression on intrinsic renal cells ficiency in glomerular diseases may indicate a possible
role for these cells in the progression of renal disease.We could not detect any CCR5 expression on intrinsic
renal cells, be it in glomerular, tubulointerstitial, or vas- The prognostic value of CCR5-positive cells for the de-
Segerer and Mack et al: CCR5 in human kidney diseases 63
used by MCP-2 on activated T cells. Cell Immunol 189:160–168,velopment of interstitial fibrosis and renal insufficiency
1998
will have to await a future longitudinal study. The ab- 14. Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, Naga-
sence of CCR5 on monocytes/macrophages in the glo- shima KA, Cayanan C, Maddon PJ, Koup RA, Moore JP, Paxton
WA: HIV-1 entry into CD41 cells is mediated by the chemokinemerulus, on the other hand, argues in favor of other
receptor CC-CKR-5. Nature 381:667–673, 1996chemokine receptors as contributors to the glomerular 15. Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart
macrophage infiltration in proliferative glomerulonephri- M, Di Marzio P, Marmon S, Sutton RE, Hill CM, Davis CB,
Peiper SC, Schall TJ, Littman DR, Landau NR: Identificationtis. The further identification of the specific chemokine
of a major co-receptor for primary isolates of HIV-1. Naturereceptors on the different leukocyte populations and 381:661–666, 1996
their role in renal diseases may then allow therapeutic 16. Choe H, Farzan M, Sun Y, Sullivan N, Rollins B, Ponath PD,
Wu L, Mackay CR, Larosa G, Newman W, Gerard N, Gerardinterventions directed at specific chemokine receptors.
C, Sodroski J: The beta-chemokine receptors CCR3 and CCR5
facilitate infection by primary HIV-1 isolates. Cell 85:1135–1148,
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